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ABSTRACT Pseudomonas aeruginosa causes numerous acute and chronic opportu-
nistic infections in humans. One of its most formidable weapons is a type III secre-
tion system (T3SS), which injects powerful toxins directly into host cells. The toxins
lead to cell dysfunction and, ultimately, cell death. Identification of regulatory path-
ways that control T3SS gene expression may lead to the discovery of novel thera-
peutics to treat P. aeruginosa infections. In a previous study, we found that expres-
sion of the magnesium transporter gene mgtE inhibits T3SS gene transcription.
MgtE-dependent inhibition appeared to interfere with the synthesis or function of
the master T3SS transcriptional activator ExsA, although the exact mechanism was
unclear. We now demonstrate that mgtE expression acts through the GacAS two-
component system to activate rsmY and rsmZ transcription. This event ultimately
leads to inhibition of exsA translation. This inhibitory effect is specific to exsA as
translation of other genes in the exsCEBA operon is not inhibited by mgtE. Moreover,
our data reveal that MgtE acts solely through this pathway to regulate T3SS gene
transcription. Our study reveals an important mechanism that may allow P. aerugi-
nosa to fine-tune T3SS activity in response to certain environmental stimuli.
IMPORTANCE The type III secretion system (T3SS) is a critical virulence factor uti-
lized by numerous Gram-negative bacteria, including Pseudomonas aeruginosa, to in-
toxicate and kill host cells. Elucidating T3SS regulatory mechanisms may uncover tar-
gets for novel anti-P. aeruginosa therapeutics and provide deeper understanding of
bacterial pathogenesis. We previously found that the magnesium transporter MgtE
inhibits T3SS gene transcription in P. aeruginosa. In this study, we describe the
mechanism of MgtE-dependent inhibition of the T3SS. Our report also illustrates
how MgtE might respond to environmental cues, such as magnesium levels, to fine-
tune T3SS gene expression.
KEYWORDS ExsA, GacAS, MgtE, Pseudomonas aeruginosa, RsmA, gene regulation,
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The Gram-negative bacterium Pseudomonas aeruginosa is implicated in a wide rangeof opportunistic infections in humans (1, 2). A major virulence factor used by P.
aeruginosa to initiate acute infections is a type III secretion system (T3SS) (3, 4). This
macromolecular apparatus spans the bacterial cell envelope and acts like a syringe,
injecting several toxins directly into host cells (5). This leads to actin cytoskeleton
rearrangement, host cell rounding, and cell death (5, 6). These actions promote tissue
damage and decrease phagocytic clearance (7–9). In addition to acute infections, P.
aeruginosa is also able to establish chronic infections through formation of biofilms,
most notably in the airways of cystic fibrosis (CF) patients (9, 10). During P. aeruginosa
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biofilm formation, altered gene regulation typically leads to a reduction in T3SS gene
expression (9, 11–14). Additionally, isolates from chronically colonized CF patients
usually contain mutations that decrease T3SS production (9, 15). Thus, during both
acute and chronic infections, P. aeruginosa appears to tightly regulate T3SS gene
expression in response to environmental conditions.
P. aeruginosa T3SS gene expression is controlled by the master transcription factor
ExsA, which is responsible for activating transcription of all T3SS genes, including exsA
itself (16). Under noninducing conditions, ExsA is bound by the antiactivator protein
ExsD and is unable to bind to its target promoters to initiate gene transcription. Two
other proteins important for T3SS regulation, ExsC and ExsE, form a separate complex.
Under inducing conditions (contact of P. aeruginosa with host cells, the presence of
serum, or low-Ca2 conditions), ExsE is secreted through the T3SS apparatus, thus
permitting ExsC to sequester ExsD. ExsA, released from ExsD, subsequently activates
the T3SS regulon. This mechanism has been referred to as “intrinsic regulation” (16).
In addition to the ExsDCE network, several other pathways also control exsA
expression and/or synthesis (9, 16). These pathways work concurrently but distinctly
from “intrinsic regulation” to further control T3SS gene expression and are referred to
as “extrinsic regulation.” One example of extrinsic regulation is the RsmA/RsmY/RsmZ
signaling cascade. RsmA is an RNA binding protein belonging to the CsrA family (17).
CsrA family members regulate gene expression at the posttranscriptional level by
binding to target mRNAs at conserved sequence motifs and impacting their stability
and/or translation (17). RsmA appears to control T3SS gene expression by increasing
exsA translation through an undetermined mechanism (18). This activity depends upon
the concentration of free RsmA in the cell and is controlled by two noncoding RNAs,
RsmY and RsmZ (18, 19). RsmY and RsmZ function by directly sequestering RsmA from
target mRNA (18, 20–22) and are thus negative regulators of ExsA synthesis. Transcrip-
tion of rsmYZ is directly controlled by the GacAS two-component system (TCS) (17, 18,
23, 24). The environmental signals governing RsmY and RsmZ expression are poorly
understood but include two additional sensor kinases, LadS and RetS. Both GacS and
LadS are able to phosphorylate the GacA response regulator to enhance rsmY and rsmZ
transcription (25, 26). In contrast, RetS inhibits GacA-mediated rsmY and rsmZ tran-
scription by forming a heterodimer with GacS and preventing GacA phosphorylation
(27). Though this pathway controls production of ExsA, the availability of ExsA to
regulate T3SS gene expression is still dependent on the intrinsic regulation described
above.
Previous studies found that the P. aeruginosa inner membrane magnesium trans-
porter MgtE inhibits T3SS gene expression (28). Whereas anmgtEmutant demonstrates
enhanced T3SS gene expression, mgtE overexpression inhibits the T3SS (28). The
mechanism by which mgtE inhibits the T3SS was not elucidated in these prior studies,
although the effect of MgtE on T3SS gene expression is distinct from its role as an Mg2
transporter in P. aeruginosa (28). Additionally, deletion of both mgtE and exsA results in
negligible T3SS activity (28), indicating that MgtE acts through ExsA to regulate T3SS
gene expression. In the present study, we show that mgtE expression inhibits ExsA
translation by increasing rsmY and rsmZ transcription. We also demonstrate that mgtE
acts exclusively through the RsmA/RsmY/RsmZ signaling pathway to inhibit ExsA-
mediated T3SS gene transcription. Because mgtE transcription is significantly upregu-
lated by growth under low-Mg2 conditions and in the presence of some antibiotics
(29, 30), this pathway may provide a mechanism for P. aeruginosa to modulate T3SS
gene expression in response to signals encountered during infections.
RESULTS
MgtE inhibits T3SS gene expression at the posttranscriptional level. Previous
studies found that mgtE expression inhibits T3SS gene transcription by acting through
ExsA (28). We considered three possibilities to account for the inhibitory effect of mgtE
expression: (i) reduced exsA transcription, (ii) reduced ExsA synthesis, and/or (iii)
impaired ExsA function. Because exsA regulates its own transcription (by acting at the
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PexsC promoter to control transcription of the exsCEBA operon) (31), it was necessary to
uncouple exsA transcription from its own control to analyze potential mgtE effects on
exsA transcription. To this end, we used the previously described P. aeruginosa UY241
strain (32), in which the ExsA-dependent PexsC promoter has been replaced with a
constitutive variant of the PlacUV5 promoter (Pcon). Removal of the native promoter
should uncouple exsCEBA transcription from activity of regulatory molecules that
naturally bind to the PexsC promoter. Indeed, UY241 has been shown to display
constitutive exsA transcription (32). As a control, PexsD-lacZ reporter activity (as a marker
for ExsA-dependent transcription) was measured in wild-type (WT) PA103 and the
UY241 strain following growth under noninducing (high-calcium [–EGTA]) and inducing
(low-calcium [EGTA]) conditions for T3SS gene expression (33–35). Whereas ExsA is
sequestered by ExsD in the WT strain under noninducing conditions and PexsD-lacZ
reporter activity is low, EGTA stimulation results in the release of ExsA from ExsD and
induction of PexsD-lacZ reporter activity (Fig. 1A) (36). Strain UY241 also demonstrates
EGTA-dependent induction of PexsD-lacZ reporter activity, but the overall level of
activity is reduced due to the lack of ExsA autoregulation at the PexsC promoter (Fig. 1A).
We next expressed mgtE in the WT (Fig. 1B) and UY241 strains (Fig. 1C) and measured
PexsD-lacZ reporter activity. In both the WT and UY241 strains, mgtE expression resulted
in a significant reduction in PexsD-lacZ reporter activity. Because native transcriptional
control has been lost in the UY241 strain, these data suggest that MgtE inhibits T3SS
gene expression by acting on ExsA at a posttranscriptional level. mgtE expression
appears to lead to less T3SS inhibition in UY241 compared to wild-type PA103 (Fig. 1B
and C). We attribute this to ExsA autoregulation in the wild type; uninhibited ExsA levels
are higher in the wild type than in UY241 (leading to the higher T3SS gene expression
seen in Fig. 1A), and so mgtE-mediated inhibition has an apparent greater effect.
Importantly, we found that mgtE expression in PA103 resulted in an approximately
100-fold increase inmgtE transcript abundance compared to the vector control (see Fig.
S1A in the supplemental material). This increase is concordant with transcript levels
seen in physiologically relevant concentrations of antibiotics and magnesium (29, 30).
Similar results were obtained with P. aeruginosa strain PA14 (Fig. S1B).
ExsA translation is repressed by mgtE expression. We next tested the hypothesis
that mgtE expression inhibits ExsA translation. We introduced the mgtE expression
vector (pmgtE) into a panel of WT PA103 strains carrying lacZ translational reporters
within the exsCEBA operon, wherein lacZ is fused at exsC codon 15 (exsC=-=lacZ), exsE
codon 15 (exsCE=-=lacZ), exsB codon 2 (exsCEB=-=lacZ), or exsA codon 77 (exsCEBA=-=lacZ)
FIG 1 mgtE inhibits T3SS gene expression at the posttranscriptional level. (A) PA103 PexsD-lacZ (WT) and UY241 were assayed under either
T3SS-noninducing (–EGTA) or -inducing (EGTA) conditions and assayed for -galactosidase activity from the PexsD-lacZ reporter construct. The
percentage of activity was calculated considering the PexsD-lacZ activity in EGTA-treated WT as 100%. *, P  0.0005; n.s., not significant. (B) PA103
PexsD-lacZ (WT) with either the vector control or pmgtE was assayed under T3SS-inducing conditions, and -galactosidase activity from the
PexsD-lacZ construct was measured. The percentage of activity was calculated considering the PexsD-lacZ activity in the WT with blank vector as
100%. **, P  0.05. (C) Strain UY241 with either the vector control or pmgtE was assayed under T3SS-inducing conditions, and -galactosidase
activity from the PexsD-lacZ construct was measured. The percentage of activity was calculated considering the PexsD-lacZ activity in UY241 with
blank vector as 100%. ***, P  0.005.
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(18); for reference, the full exsCEBA operon is diagrammed in Fig. 2A. Each reporter is
integrated in single copy on the chromosome at the CTX phage attachment site and
transcribed from a constitutive PlacUV5 promoter. Whereas plasmid-expressedmgtE reduced
exsCEBA=-=lacZ translational reporter activity by almost 3-fold (Fig. 2B), mgtE had no nega-
tive impact on the exsC=-=lacZ (Fig. 2C), exsCE=-=lacZ (Fig. 2D), or exsCEB=-=lacZ (Fig. 2E)
reporter activities. We found a similar decrease in exsCEBA=-=lacZ reporter activity in P.
aeruginosa strain PA14 (see Fig. S2 in the supplemental material). These data suggest
that mgtE expression inhibits ExsA translation and that this activity is specific to exsA in
the exsCEBA operon. For reasons that are unclear, the exsCEB=-=lacZ reporter showed a
significant increase upon mgtE expression.
The small intergenic region between exsB and exsA contains a minor, Vfr-dependent
promoter (PexsA) that controls exsA transcription (37). Because the PexsA promoter is
present in the exsCEBA=-=lacZ translational reporter, we considered the possibility that
the observed reduction in exsCEBA=-=lacZ activity (Fig. 2A) resulted from MgtE tran-
scriptional inhibition of PexsA promoter activity. To investigate this hypothesis, we
monitored the effect of mgtE expression on a cyclic AMP (cAMP)-Vfr signaling (CVS)
reporter (38). The CVS reporter consists of lacZ fused to the cAMP- and CRP/Vfr-
dependent lacP1 promoter from Escherichia coli. As shown in Fig. S3A in the supple-
mental material, mgtE expression had no significant effect on CVS reporter activity. This
result is further supported by the finding that mgtE expression in a vfr mutant still
inhibits PexsD-lacZ activity (Fig. S3B). We infer from these data that mgtE does not alter
transcription from the PexsA proximal promoter, which is consistent with the conclusion
that mgtE affects ExsA at a posttranscriptional level.
It is also possible that mgtE decreases exsA mRNA stability rather than specifically
inhibiting exsA translation. To distinguish between these two possibilities, we isolated
mRNA from UY241, carrying either a vector control or pmgtE, and performed quanti-
tative reverse transcription-PCR (qRT-PCR) using primer pairs designed to amplify a
central region of exsA (see Materials and Methods). Intriguingly, mgtE expression
increased exsA transcript levels (Fig. 3). The same effect was also observed in the strain
carrying the exsCEBA=-=lacZ translational reporter used for the experiment in Fig. 2 (see
Fig. S4 in the supplemental material). These findings suggest that mgtE might have
positive effects on exsA mRNA stability, but more importantly, they strongly suggest
that the posttranscriptional inhibition of ExsA synthesis by mgtE is due to repression of
ExsA translation as opposed to impaired exsA mRNA stability.
FIG 2 mgtE expression specifically represses exsA translation. (A) Diagram of the exsCEBA operon. (B to E) Translational exsA (exsCEBA=-=lacZ) (B), exsC (exsC=-=lacZ)
(C), exsE (exsCE=-=lacZ) (D), and exsB (exsCEB=-=lacZ) (E) reporter strains, with either the vector control or pmgtE, were assayed under T3SS-inducing (EGTA)
conditions for -galactosidase activity. The percentage of activity was calculated considering the lacZ activity from the respective strains with the blank vector
as 100%. The reporter constructs were transcribed from a constitutive PlacUV5 promoter. The particular translational fusion tested in each panel is diagrammed
above each graph. *, P  0.005; **, P  0.05; n.s., not significant.
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mgtE upregulates rsmY and rsmZ transcription in a GacAS dependent manner.
We next examined possible mechanisms for the mgtE-mediated exsA inhibition. We
reasoned that since mgtE is an inner membrane protein (28), its translation-repressive
effects on exsA were likely indirect—possibly by stimulating one of the established
signaling pathways that control ExsA translation. For this reason, we investigated
whether mgtE affected RsmA/RsmY/RsmZ signaling (18). To explore this hypothesis, we
measured PrsmY-lacZ, PrsmZ-lacZ, and PrsmA-lacZ transcriptional reporter activity (18) and
found that mgtE expression significantly upregulates rsmY and rsmZ transcription by
approximately 2.5-fold and 2-fold, respectively (Fig. 4A and B). In PA14 strains contain-
ing these constructs, mgtE expression also significantly enhanced rsmY and rsmZ
transcription (see Fig. S5 in the supplemental material). Interestingly, mgtE expression
also stimulated rsmA transcription (Fig. 4C), but to a smaller degree than measured for
rsmY and rsmZ. Because the GacAS two-component system is essential for rsmY and
rsmZ transcription (17, 18, 23, 24), we hypothesized that themgtE effect requires GacAS.
As evident from Fig. 4A and B, mgtE expression failed to stimulate PrsmY-lacZ and
PrsmZ-lacZ reporter activities in the absence of either gacA or gacS, thus supporting a
role for GacAS in mgtE-mediated RsmYZ regulation.
FIG 3 exsA mRNA remains stable upon mgtE expression. mRNA was isolated from P. aeruginosa UY241
containing either the vector control or pmgtE, and exsA transcript stability was analyzed by qRT-PCR. exsA
transcript abundance was normalized to that of the control transcript fbp. *, P  0.05.
FIG 4 mgtE expression affects Rsm signaling by a GacAS-dependent mechanism. Transcriptional rsmY (PrsmY-lacZ) (A), rsmZ (PrsmZ-lacZ) (B),
and rsmA (PrsmA-lacZ) (C) reporter strains in the WT, ΔgacA, and ΔgacS backgrounds with either the vector control or pmgtE were assayed
under T3SS-inducing (EGTA) conditions for -galactosidase activity. The percentage of activity was calculated considering the lacZ
activity from the respective WT reporter strains with the blank vector as 100%. *, P  0.01; n.s., not significant (ANOVA).
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mgtE expression in an rsmY rsmZ mutant fails to inhibit T3SS gene expression.
Since our data suggest that mgtE affects RsmA/RsmY/RsmZ signaling to inhibit exsA
translation, we next tested whether the effect of MgtE functions solely through
RsmA/RsmY/RsmZ signaling to inhibit ExsA-dependent transcription by expressing
mgtE in an rsmY rsmZ double mutant. Consistent with a previous report (16), the rsmY
rsmZ mutant demonstrates increased PexsD-lacZ reporter activity compared to the WT
(Fig. 5). Whereas mgtE expression significantly inhibited PexsD-lacZ reporter activity in
the WT background, reporter activity was unaffected in the rsmY rsmZ mutant (Fig. 5).
These data suggest that mgtE works solely through the RsmA/RsmY/RsmZ signaling
cascade to inhibit exsA translation.
Previous studies identified an interaction between mgtE and algR during T3SS
transcriptional regulation, though the nature of this interaction was unclear (30).
Among other activities, the AlgZR two-component system inhibits T3SS gene expres-
sion (30, 39); one mechanism by which this occurs is by enhancing rsmY and rsmZ
transcription, thus inhibiting ExsA translation (18). Therefore, we considered the pos-
sibility that MgtE could additionally stimulate rsmY and rsmZ transcription through
AlgZR. However,mgtE expression inhibited PexsD-lacZ reporter activity, even in an algZR
deletion mutant (Fig. 6), suggesting thatmgtE-mediated T3SS repression does not work
directly through AlgZR.
DISCUSSION
The central role of ExsA as the primary regulator of P. aeruginosa T3SS makes it an
attractive target for therapeutic development (16). Defining signaling networks that
FIG 5 RsmYZ are required for MgtE-mediated inhibition of T3SS gene transcription. PA103 PexsD-lacZ and
ΔrsmYZ PexsD-lacZ strains with either the vector control or pmgtE were assayed under T3SS-inducing
(EGTA) conditions for -galactosidase activity from the PexsD-lacZ reporter construct. The percentage of
activity was calculated considering the PexsD-lacZ activity in WT with blank vector as 100%. *, P  0.01;
n.s., not significant (ANOVA).
FIG 6 mgtE inhibits T3SS gene transcription in a algZR background. ΔalgZR strains with either the
vector control or pmgtE were assayed under T3SS-inducing (EGTA) conditions for -galactosidase
activity from the PexsD-lacZ reporter construct. The percentage of activity was calculated considering the
PexsD-lacZ activity in the ΔalgZR strain with blank vector as 100%. *, P  0.0005.
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control exsA expression, synthesis, and activity is critical to realizing that goal. Previous
work found that the MgtE magnesium transporter inhibits T3SS gene expression (28);
mgtE gene expression inhibits, while mgtE deletion enhances, T3SS. In this study, we
demonstrate that MgtE accomplishes this activity by inhibiting exsA translation (Fig. 7).
Considering the function of MgtE, it is intriguing to speculate that magnesium con-
centration fluctuations could mediate toxicity changes. However, as magnesium has
pleiotropic effects on P. aeruginosa (40), this signaling is likely complex.
MgtE-mediated inhibition of exsA translation appears to occur through the RsmA/
RsmY/RsmZ pathway (Fig. 4 and 5). Increased RsmY and RsmZ levels sequester RsmA,
resulting in decreased exsA translation. Importantly, we found that mgtE expression
does not decrease exsA transcript levels (Fig. 3), further supporting the conclusion of a
specific effect on translation. Additionally, lack of involvement of Vfr in MgtE-mediated
T3SS gene transcription inhibition strongly indicates that exsA translation inhibition is
not the result of decreased transcription activity from the PexsA promoter located on
translational fusion constructs (see Fig. S3 in the supplemental material). The fact that
MgtE does not inhibit other genes in the exsCEBA operon (Fig. 2) suggests that there
may be regulatory sequences specific to exsA translational control. However, it is also
formally possible that the lack of additional coding sequences for these other genes
masks any potential effects MgtE exerts on downstream motifs. There does seem to be
a stronger inhibition by mgtE in the Δvfr strain compared to vfr-competent strains (Fig.
1 versus Fig. S3B). The reasons for this effect are unclear, but it could be the result of
competing effects on T3SS expression through the Vfr/CVS and Rsm pathways, an
as-yet-unidentified Vfr pathway, or simply stochastic variation.
Overexpression of mgtE also enhances rsmA transcription (Fig. 4C), although to a
much lesser degree than rsmY and rsmZ (Fig. 4A and B). As was proposed in another
study, it is plausible that the net result from increased rsmA, rsmY, and rsmZ transcrip-
tion is reduced RsmA availability (18). First, RsmA positively regulates rsmY and rsmZ
transcription, which likely plays a role in maintaining homeostasis (18, 41). Second,
RsmA binds to its own mRNA to repress translation (42). Therefore, themgtE-dependent
increase in rsmA, rsmY, and rsmZ expression could result in reduced RsmA availability
and decreased exsA translation (Fig. 2).
MgtE lacks helix-turn-helix or other DNA binding motifs (43, 44), which would be
needed to directly impact transcription. Therefore, it seems that the positive effect of
MgtE on rsmY and rsmZ transcription is indirect. This is indeed supported by our data
that mgtE expression fails to affect rsmY and rsmZ transcription in both a gacA mutant
and a gacS mutant (Fig. 4A and B). These results also establish that MgtE influences
rsmY and rsmZ transcription through GacAS. As a membrane protein, MgtE could be
involved in direct or indirect binding interactions with GacS, LadS, RetS, or a novel
membrane protein that affects signaling through GacS. Because MgtE signals through
FIG 7 A model formgtE-mediated control of T3SS. MgtE affects signaling through GacAS, by an unknown
mechanism, to stimulate transcription of rsmY and rsmZ. Increased rsmY or rsmZ levels, in turn, sequester
RsmA, preventing it from enhancing translation of exsA, thus inhibiting T3SS gene transcription. IM, inner
membrane.
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GacA and GacS, it would be interesting to investigate whether MgtE expression leads
to higher phosphorylated states of GacA. It is important to note that RetS was found to
regulate biofilm formation in response to magnesium limitation (45), a condition that
also enhances mgtE transcription (29). Additionally, a recent report showed that AlgR
influences rsmY and rsmZ activity through an unknown mechanism (18). However, we
found that mgtE expression still repressed T3SS transcription in a ΔalgZR background
(Fig. 6), indicating that MgtE affects RsmY and RsmZ levels solely through GacAS. Future
work will investigate the mechanism by which mgtE affects GacAS signaling.
It is noteworthy thatmgtE transcription is significantly upregulated under low-Mg2
and high-antibiotic conditions (29, 30), which are commonly found during host infec-
tions like in the CF lung environment (46–52). We expressed mgtE from a plasmid to
simulate the effects of high mgtE expression (Fig. S1), such as could occur during host
infection. Thus, our study describes a mechanism that might allow P. aeruginosa to
respond to the host environment and optimize T3SS gene expression. Additionally,
because MgtE signals through GacAS, our results indicate two environmental signals
encountered by P. aeruginosa during infection (low Mg2 concentrations and high
antibiotic concentrations during infection) that potentially affect the GacAS signaling
pathway. Thus, it is possible that MgtE serves as a sensor, altering T3SS expression in
response to changes in the extracellular environment (i.e., magnesium levels and
antibiotics). Because the effects on exsA levels and T3SS gene expression are modest
(Fig. 1, 2, and 5) (28), we propose that MgtE “fine-tunes” the T3SS response in
accordance with the chemical environment, rather than acting as a binary on/off
switch.
MgtE is important for the pathogenesis of other microorganisms, such as Aeromonas
hydrophila and Campylobacter jejuni (53, 54). A. hydrophila, in particular, has both a T3SS
and an RsmA homologue (55, 56). An intriguing avenue of future research will be to
investigate whether MgtE homologs in other pathogens inhibit T3SS through a con-
served mechanism of action (i.e., modulation of RsmA activity). Similar to MgtE in P.
aeruginosa, the housekeeping Mg2 transporter CorA, found in numerous bacteria, is
reported to transport Mg2 and modulate virulence as two distinct functions (57).
Future work will investigate whether CorA signaling is similar to that of P. aeruginosa
MgtE.
Taken together, the results of our present study describe the mechanism by which
MgtE influences T3SS in P. aeruginosa: by inhibiting exsA translation, which, in turn,
leads to downstream effects on ExsA-mediated T3SS gene transcription. This signaling
cascade is one mechanism used by P. aeruginosa to respond to Mg2 scarcity and
high-antibiotic conditions. Additional characterization of upstream events of this sig-
naling cascade (i.e., how MgtE affects GacAS signal transduction) would further increase
our understanding of the mechanism used by P. aeruginosa to orchestrate signaling
pathways in response to the host environment.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in this study are listed in Table
1. Expression of mgtE was accomplished by transforming the indicated strains with plasmid pmgtE (28),
which contains the full-length mgtE gene immediately downstream from the ParaBAD promoter on vector
pMQ72 (58). This promoter is leaky in P. aeruginosa, and we have previously found mgtE expression in
the absence of arabinose induction (28). Plasmids were maintained in Escherichia coli S17 (28) cultured
on LB agar plates or LB containing 10 g/ml gentamicin; we used Miller’s LB (10 g/liter tryptone, 5 g/liter
yeast extract, 10 g/liter NaCl). Plasmids were isolated from E. coli using a QIAprep spin miniprep kit
(Qiagen) according to the manufacturer’s instructions and electroporated into the appropriate P.
aeruginosa strains. Transformed P. aeruginosa cells were cultured in Vogel Bonner minimal (VBM) medium
(18, 59) agar plates with 60 g/ml gentamicin, and the presence of the respective plasmids was
confirmed by PCR with primers p729 (5=-CAGACCGCTTCTGCGTTCTG-3=) and p730 (5=-GCAACTCTCTACT
GTTTCTCC-3=) (30). These primers bind to sequences on vector pMQ72 that flank the mgtE insertion site.
For -galactosidase assays, P. aeruginosa strains were cultured overnight on VBM agar plates with
gentamicin. Cells were subcultured the next day to a starting concentration at an optical density at 600
nm (OD600) of 0.1 in Trypticase soy broth (TSB) supplemented with 100 mM monosodium glutamate and
1% glycerol (18). EGTA (2 mM) was added to the medium to activate T3SS gene expression, through
induction of the intrinsic regulatory cascade (i.e., secretion of ExsE, leading to desequestration of the
T3SS activator ExsA) (33, 60).
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Genetic manipulations. PA14 PlacUV5-exsCEBA=-=lacZ was constructed by conjugation of plasmid
p3UY51 (18) from Escherichia coli strain S17 into PA14. PA14 PrsmY-lacZ and PA14 PrsmZ-lacZ were
constructed by conjugation of plasmids mini-CTX-PrsmY-lacZ and mini-CTX-PrsmY-lacZ (18), respectively,
into PA14. Exconjugants were selected on VBM plates with tetracycline, as described above.
-Galactosidase assays. P. aeruginosa was grown to an OD600 of 1.0, and -galactosidase activity
was measured as reported earlier (18). ortho-Nitrophenyl--D-galactopyranoside (ONPG) was used as the
substrate for -galactosidase in all the -galactosidase assays involving transcriptional reporters; chlo-
rophenol red–-D-galactopyranoside (CPRG) was used as the substrate in assays involving translational
reporters (18, 61). Plasmid pmgtE (28) and its empty backbone vector pMQ72 (58) were used to assess
the effect of mgtE expression on transcription and translation.
RNA isolation and real-time qRT-PCR. P. aeruginosa strains were cultured as described above for
-galactosidase assays and harvested at an OD600 of 1.0, whereupon the pellet was washed with
phosphate-buffered saline (PBS). This was followed by RNA isolation using the RNeasy Plus kit (Qiagen)
according to the manufacturer’s instructions. A few modifications were made to the protocol, as
described earlier (30). Briefly, the RNA was subjected to on-column DNase digestion prior to elution.
Additionally, after elution, a second DNase digestion was performed, followed by the RNA cleanup
procedure. These digestions result in negligible DNA contamination of the final isolated RNA sample (30).
cDNA was synthesized from the RNA using the Superscript III first-strand synthesis system for RT-PCR
(Invitrogen), according to the manufacturer’s guidelines (30). DNA contamination of the RNA prepara-
tions was tested in control reactions by performing cDNA synthesis in the absence of reverse transcrip-
tase. Real-time quantitative reverse transcription-PCR (qRT-PCR) was performed as previously reported
(30) using the following primers: exsARTfor (5=-GCTGATGCTCTTCGCGTTCAGTCC-3=) and exsARTrev (5=-
TGGGCATAGAGGATTCTCCGCTCG-3=), which amplify exsA from nucleotides 436 to 676; mgtERTforNewest
(5=-AAGCAAGTGCTGGAAGTCATGG-3=) and mgtERTrevNewest (5=-ATGTTGAGGACTTCGCTTTCGC-3=),
which amplify mgtE from nucleotides 332 to 587; and lacZRTfor (5=-CAACTGTTTACCTTGTGGAG-3=) and
lacZRTrev (5=-TATGAACGGTCTGGTCTTTG-3=), which amplify the lacZ transcript from nucleotides 2271 to
4800. Samples were normalized to the fbp transcript using primers PA5110for (5=-CCTACCTGTTGGTCTT
CGACCCG-3=) and PA5110rev (5=-GCTGATGTTGTCGTGGGTGAGG-3=) (28, 30, 62, 63).
Statistical analyses. At least three independent experiments were performed for each assay. A
two-sample Student t test was used to determine statistical significance (P  0.05). For multiple
comparisons, a one-way analysis of variance (ANOVA) with Tukey’s honestly significant difference (HSD)
post hoc test was used to determine statistical significance (P  0.05).
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TABLE 1 Bacterial strains used in this study
Strain Relevant characteristic(s)
Reference(s) or
source
PA103 PexsD-lacZ WT strain with ExsA-dependent PexsD-lacZ reporter chromosomally integrated at CTX site 4, 10, 18, 64
UY241 Constitutive transcription of exsCEBA in PA103 PexsD-lacZ background 32
PA14 WT strain 65
PA103 PlacUV5-exsCEBA=-=lacZ PlacUV5-driven exsA translational reporter integrated at CTX site 18
PA103 PlacUV5-exsCEB=-=lacZ PlacUV5-driven exsB translational reporter integrated at CTX site 18
PA103 PlacUV5-exsCE=-=lacZ PlacUV5-driven exsE translational reporter integrated at CTX site 18
PA103 PlacUV5-exsC=-=lacZ PlacUV5-driven exsC translational reporter integrated at CTX site 18
PA14 PlacUV5-exsCEBA=-=lacZ PlacUV5-driven exsA translational reporter integrated at CTX site This study
PA103 CVS PlacP1-lacZ reporter for cAMP-Vfr signaling 38
PA103 PexsD-lacZ Δvfr Isogenic deletion of vfr in PA103 PexsD-lacZ background 18
PA103 PexsD-lacZ ΔalgZR Isogenic deletions of algZ and algR in PA103 PexsD-lacZ background 18
PA103 PexsD-lacZ ΔrsmYZ Isogenic deletions of rsmY and rsmZ in PA103 PexsD-lacZ background 18
PA103 PrsmY-lacZ rsmY transcriptional reporter chromosomally integrated at CTX site 18
PA103 PrsmZ-lacZ rsmZ transcriptional reporter chromosomally integrated at CTX site 18
PA103 PrsmA-lacZ rsmA transcriptional reporter chromosomally integrated at CTX site 18, 66
PA103 PrsmY-lacZ ΔgacA Isogenic deletion of gacA in PA103 PrsmY-lacZ background 18
PA103 PrsmY-lacZ ΔgacS Isogenic deletion of gacS in PA103 PrsmY-lacZ background 18
PA103 PrsmZ-lacZ ΔgacA Isogenic deletion of gacA in PA103 PrsmZ-lacZ background 18
PA103 PrsmZ-lacZ ΔgacS Isogenic deletion of gacS in PA103 PrsmZ-lacZ background 18
PA14 PrsmY-lacZ rsmY transcriptional reporter chromosomally integrated at CTX site This study
PA14 PrsmZ-lacZ rsmZ transcriptional reporter chromosomally integrated at CTX site This study
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